Regulatory Platform within Swiss Biotech Association's Community (digital networking) is accessible for our members.
Platform Leaders - Heike Bihlmann and Cathy Kroll
Regulatory issues are of great consequence to academia and industry researchers active in drug discovery and development.
The drug discovery and development process is extremely complex, especially for academics in biotech research as well as for small and medium sized start-ups from academia or spin-offs from industry. The issue is not so much the quality of the research but the knowledge and know-how on the relevant challenges and hurdles throughout the development process as well as an overview on methods and principles.